IP Library › Granted Patent US 8,101,745
Granted Patent B2
US 8,101,745 · App. 11/793,276 · Granted Jan 24, 2012

Lung-targeted drugs

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,101,745
App. No.
11/793,276
Granted
Jan 24, 2012
Kind
B2
Abstract

Methods and compositions are provided for treating lung diseases, including but not limited to infections and small cell and non-small cell lung cancer, by conjugating a drug of interest to glycerol ethers or glycerol phosphate ethers.

Claims (6)

1. A compound having the structure

or pharmaceutically acceptable salt thereof.

2. A compound having the structure

or pharmaceutically acceptable salt thereof.

3. A compound having the structure

or pharmaceutically acceptable salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2008
From: HOSTETLER, KARL Y.; BEADLE, JAMES R.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 020856/0198 →
Continuity (2)
Provisional Application 60637195 · Dec 16, 2004
Related Publication 20080221061A1 · Sep 11, 2008